To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Global Varicose Veins Treatment Market size was valued at USD 1.22 Billion in 2021 and is poised to grow from USD 1.3 Billion in 2022 to USD 2.12 Billion by 2030, at a CAGR of 6.32% during the forecast period (2023-2030).

The global varicose veins treatment market is characterized by a competitive landscape with several players striving to capture a significant market share. These market participants include manufacturers, healthcare providers, research institutions, and other stakeholders involved in the development, production, and distribution of varicose veins treatment solutions. The competition in the market is driven by factors such as product efficacy, safety, innovation, pricing strategies, and geographic presence. Companies in the market focus on developing and launching technologically advanced treatment options to meet the growing demand for minimally invasive procedures. Research and development efforts are directed towards enhancing the effectiveness of existing treatments and exploring novel therapeutic approaches. 'Medtronic (Ireland)', 'AngioDynamics (US)', 'Lumenis (Israel)', 'Syneron Medical Ltd. (Israel)', 'Biolitec AG (Germany)', 'BTG International Ltd. (UK)', 'Vascular Solutions, Inc. (US)', 'Energist Group (UK)', 'Eufoton (Italy)', 'Quanta System (Italy)', 'Miravas (France)', 'Vein Clinics of America (US)', 'Alna-Medical System GmbH (Germany)', 'Miravas SAS (France)', 'Sciton, Inc. (US)', 'Dornier MedTech GmbH (Germany)', 'LSO Medical (France)', 'Vascular Insights, LLC (US)', 'WONTECH Co., Ltd. (South Korea)', 'LSO Medical SAS (France)'

Increased awareness and education regarding varicose veins and available treatment options have contributed to market growth. Public awareness campaigns, patient education initiatives, and information dissemination through various channels have encouraged individuals with varicose veins to seek appropriate treatment.

Growing Emphasis on Combination Therapies: Combination therapies involving multiple treatment modalities are gaining popularity in varicose veins treatment. Combining procedures such as endovenous ablation and sclerotherapy can optimize outcomes by targeting different aspects of the venous disease, leading to improved efficacy and patient satisfaction.

North America emerged as the dominant market, accounting for a revenue share. This can be attributed to a significant patient base in the region, with a strong emphasis on aesthetics. People in North America are increasingly willing to undergo cosmetic procedures due to the noticeable results and perceived safety. Laser treatments, in particular, have played a significant role in reducing the stigma associated with cosmetic procedures and gaining social acceptance, especially among men. The demonstrated safety and efficacy of laser procedures have contributed to their popularity in the region.

Feedback From Our Clients

Global Varicose Veins Treatment Market

Product ID: SQMIG35E2025